发明授权
US07495007B2 Spiroindolinone derivatives 失效
螺吲哚啉酮衍生物

Spiroindolinone derivatives
摘要:
The present invention relates to spiroindolinone derivatives of the formula and their enantiomers and pharmaceutically acceptable salts and esters thereof wherein R1, R2, R3, R4, R5, R6, R7 and R8, are as herein described. The compounds have utility as antiproliferative agents, especially, as anticancer agents.
公开/授权文献
信息查询
0/0